MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1097/mnm.0000000000001964

Медицинская библиотека · Nuclear medicine communications · 2025

A review of the association between baseline [ 18 F] fluorodeoxyglucose uptake and axillary pathological complete response in node-positive breast cancer patients: focus on clinical subtypes.

Lenaerts Melissa, van Amstel Florien J G, Mottaghy Felix M, Geurts Sandra M E, Tjan-Heijnen Vivianne C G, Smidt Marjolein L, van Nijnatten Thiemo J A

СтатьяОбзорПеревод пока не подготовлен

Аннотация

The objective is to assess whether the degree of metabolic uptake of the primary tumor and axillary lymph nodes (ALNs) on baseline [ 18 F] fluorodeoxyglucose ([ 18 F]FDG) PET/CT is associated with the probability to achieve axillary pathologic complete response (pCR) in clinically node-positive (cN+) breast cancer patients treated with neoadjuvant systemic therapy (NST), overall and per clinical subtype. Studies that assessed the maximum standardized uptake value (SUVmax) in the primary tumor and ALNs on baseline [ 18 F]FDG PET/CT and reported axillary pCR rates in patients diagnosed with cN+ invasive breast cancer treated with NST, followed by surgery, were searched. Area under the curve (AUC) values were obtained. A total of seven studies (561 patients) were included. The mean baseline SUVmax of the primary tumor ranged from 8.1 (±4.3) to 9.8 (±7.2). Mean baseline axillary SUVmax ranged from 6.0 (±5.6) to 7.3 (±6.2). The axillary pCR rate ranged from 38.0% to 48.1%. Considering the primary tumor, no study reported on the association between baseline SUVmax and the axillary pCR rate. Considering the ALNs, the AUC value for baseline axillary SUVmax to predict axillary pCR ranged from 0.52 [95% confidence interval (CI): 0.39-0.65; all subtypes included] to 0.74 (95% CI: 0.53-0.95; only human epidermal growth factor receptor 2+ and triple negative). In conclusion, no association between the primary tumor SUVmax on baseline [ 18 F]FDG PET/CT and axillary pCR was found. Concerning the axilla, based on limited scientific evidence, the axillary SUVmax on baseline [ 18 F]FDG PET/CT may be associated with axillary pCR after NST in cN+ breast cancer patients, however, potential differences between clinical subtypes should be considered.

Для цитирования: Lenaerts Melissa, van Amstel Florien J G, Mottaghy Felix M, Geurts Sandra M E, Tjan-Heijnen Vivianne C G, Smidt Marjolein L, van Nijnatten Thiemo J A. A review of the association between baseline [ 18 F] fluorodeoxyglucose uptake and axillary pathological complete response in node-positive breast cancer patients: focus on clinical subtypes.. Nuclear medicine communications. 2025. DOI: 10.1097/mnm.0000000000001964.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.